ArticleBreast cancer research : BCR2011

Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.

Nathan R West et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.